Patent 11571518 was granted and assigned to Adamis Pharmaceuticals Corporation on February, 2023 by the United States Patent and Trademark Office.
Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug to be used in a drug or substance overdose.